QA: Catalent Inc in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001596783_2020_Catalent_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Large missing amount for aggregate "Liabilities" added to remainder. industry.us_generic {'missing_ratio': 3.900377358490566, 'aggregate_val': 3895800000, 'exp_sum': 795000000, 'exp_to_value': {'LiabilitiesCurrent': 670700000, 'LiabilitiesNoncurrent': 124300000, 'remainder_Liabilities': 0}}
warning Large missing amount for aggregate "Liabilities" added to remainder. industry.us_generic {'missing_ratio': 2.89334548769371, 'aggregate_val': 4271000000, 'exp_sum': 1097000000, 'exp_to_value': {'LiabilitiesCurrent': 893000000, 'LiabilitiesNoncurrent': 204000000, 'remainder_Liabilities': 0}}

Graph

Absolute values for 0001596783, Catalent Inc

  xvar xval
0 AssetsCurrent 1,395,800,000
1 IntangibleAssetsNetIncludingGoodwill 3,151,700,000
2 PropertyPlantAndEquipmentNet 1,536,700,000
3 remainder_Assets 99,800,000
4 LiabilitiesCurrent 670,700,000
5 LiabilitiesNoncurrent 124,300,000
6 remainder_Liabilities 3,100,800,000
7 CostOfGoodsAndServicesSold 1,712,900,000
8 SellingGeneralAndAdministrativeExpense 513,882,563
9 ResearchAndDevelopmentExpense 0
10 remainder_Expenses 35,417,321
11 remainder_Revenues 2,520,708,641
12 remainder_NetIncome -119,703,171
13 remainder_ComprehensiveNetIncome -42,731,303
  yvar yval
0 Assets 6,184,000,000
1 Liabilities 3,895,800,000
2 Expenses 2,262,199,884
3 Revenues 2,520,708,641
4 StockholdersEquity 2,288,200,000
5 NetIncome 138,805,586
6 ComprehensiveNetIncome 117,439,934
7 BaseVar 7,512,571,500
8 EconomicCapitalRatiobeforeLimitedLiability 1.01
9 EconomicCapitalRatio 2.31

Edgar->Model Mapping

Feature Distribution

Change over Time